Genomtec has received a patent from the European Patent Organization (EPO) for the Genomtec®ID technology and device invented by Genomtec SA. The invention under new patent protection includes Genomtec®ID, the Company’s key technology related to a proprietary non-contact heating and temperature sensing system developed for point-of-care testing (POCT) and other applications. This is the first patent granted by EPO and the seventh received by Genomtec. The company has more than twenty patent applications pending worldwide.
“This is a tremendous achievement for us and will protect our invention in our key European market, where we are from and where we received funding to develop our technology and device. Europe is the first and primary market for us to make our genetic diagnostics platform available at the point of care” – said Miron Tokarski, co-founder and CEO of Genomtec SA. “The granting of a patent for our key technology by the European Patent Office, together with the patents already held for it in the United States and Japan, reinforces Genomtec’s value to investors and commercial partners.” – He adds.
The patent proceedings are aimed at securing key interests and are part of Genomtec’s growth strategy, which includes building up its intellectual property rights portfolio within the POCT diagnostics business area
